- Target
- NOS3/eNOS
- Reactivity
- Human,Mouse,Rat
- Application
- WB,IHC,IF,IP,ELISA
- MW(Calculated)
- 133kD
- MW(Observed)
- 133kD
- Host Species
- Rabbit
- Isotype
- IgG, Kappa
- Conjugate/Modification
- Phospho
- Modification site
- Ser1177
- Recommended Dilution Ratio
- IHC 1:200-1:1000;WB 1:2000-1:10000;IF 1:200-1:1000;ELISA 1:5000-1:20000;IP 1:50-1:200;
- Form
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Source
- --
- Purification
- Protein A
- Purity
- --
- storageCondition
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- --
- Clonality
- Monoclonal
- Clone No.
- PT0906R
- Immunogen
- --
- Sequence
- --
- Specificity
- eNOS (Phospho Ser1177) Monoclonal Antibody detects endogenous levels of eNOS around the phosphorylation site of Ser1177 protein.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):TQsFS
- Gene Name
- NOS3
- Protein Name
- Nitric oxide synthase endothelial
- Other Name
- NOS3;Nitric oxide synthase;endothelial;Constitutive NOS;cNOS;EC-NOS;Endothelial NOS;eNOS;NOS type III;NOSIII
- Organism-1
- Human
- Gene ID-1
- 4846
- SwissProt-1
- P29474
- Organism-2
- Mouse
- Gene ID-2
- 18127
- SwissProt-2
- P70313
- Organism-3
- Rat
- Gene ID-3
- 24600
- SwissProt-3
- Q62600
- Organism-4
- --
- gene ID-4
- --
- SwissProt-4
- --
- Cellular Localization
- Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity.